Allogene Therapeutics (ALLO) FCF Margin (QoQ) (2021 - 2024)

Allogene Therapeutics (ALLO) FCF Margin (QoQ) (2021 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Allogene Therapeutics 707.96 Mn 707.96 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2024 880,087.00
Dec 31, 2023 190,823.00
Sep 30, 2023 1.85 Mn
Jun 30, 2023 -5.11 Mn
Mar 31, 2023 2.09 Mn
Dec 31, 2022 -6.84 Mn
Sep 30, 2022 -11.01 Mn
Jun 30, 2022 11.20 Mn
Mar 31, 2022 -17.98 Mn
Dec 31, 2021 9.82 Mn
Sep 30, 2021 -266,229.00
Jun 30, 2021 -9.55 Mn